All News

Medtronic Announces FDA Approval of Infuse® Bone Graft for Three New Spine Surgery Indications

December 11, 2015 – Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of additional spine surgery indications for Infuse® Bone Graft. Upon receiving final labeling approval from the FDA, the company expects to begin marketing

Bone Therapeutics: ALLOB® Delayed-Union Program Awarded at Cells Orthopedics Conference

BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE), the bone cell therapy company addressing high unmet medical needs in the field of bone fracture repair and bone fracture prevention, announces that it has been awarded a gold prize for an abstract on the Phase I/IIA

Nuvasive Announces Location For New State-Of-The-Art Manufacturing Facility

SAN DIEGO, CA – December 10, 2015 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that the Company has selected a site in West Carrollton, Ohio as the

Fiagon Partners With joimax to Combine Surgical Navigation and Minimally Invasive Endoscopic Spinal Surgery

IRVINE, CA–(Marketwired – December 10, 2015) – DWG German Spine Meeting, Frankfurt -The German Fiagon AG, Henningsdorf/Berlin, a medical technology company that develops and manufactures innovative surgical navigation systems including flexible instruments, and the German company joimax® GmbH, Karlsruhe, developer and manufacturer of

BONESUPPORT™ Announces Results Of CERAMENT™|BONE VOID FILLER Prospective Pilot Study Demonstrating Complete Bone Remodeling In Benign Bone Tumors

LUND, Sweden, Dec. 10, 2015 /PRNewswire/ — BONESUPPORT™, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, today announced that the Company’s platform technology, CERAMENT™ has proven effective in the management of benign bone

CareFusion Receives Two 510(k) Clearances For Spine Products

FRANKLIN LAKES, N.J., Dec. 10, 2015 /PRNewswire/ — CareFusion, a BD company (BDX), today announced the U.S. Food and Drug Administration (FDA) has cleared two 510(k)s for its spine augmentation devices. The new 13-gauge AVAmax® Vertebral Balloon system expands the company’s offerings

NuVasive Hosts 2015 Investor Day

SAN DIEGO, CA–(Marketwired – December 10, 2015) – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, will host its 2015 Investor Day today Thursday, December 10, 2015 from 10:30 a.m. to

Stryker Declares a $0.38 per Share Quarterly Dividend

Kalamazoo, Michigan – December 10, 2015 – Stryker Corporation (SYK) announced that its Board of Directors has declared a quarterly dividend of $0.38 per share payable on January 29, 2016, to shareholders of record at the close of business on

Study links ROM after calcaneal fracture with patient-reported function, quality of reduction

By Monica Jaramillo Results of this study correlated the postoperative subtalar range of motion in patients who underwent open surgery for calcaneal fractures with Foot and Ankle Disability Index and SF-36 physical component summary scores and the subt…

EOS imaging announces record 6 installations in the US in last month

PARIS–(BUSINESS WIRE)–Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, announced today its commercial and organizational expansion to support the momentum of installations in adult and pediatric hospitals in the United States. EOS imaging’s

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1